Myositis (Idiopathic Inflammatory Myopathy, IIM) are auto-immune diseases related to muscles. They are not hereditary. They are characterized by a muscle weakness and fatigability, and very often by muscle pain (myalgia).
Clinical trial on Inclusion Body Myositis ongoing at the Institute:
- ABATACEPT : A Phase 3, Randomized, Double-Blind Clinical Trial to Evaluate the Efficacy and Safety of Abatacept SC with Standard Treatment Compared to Standard Treatment Alone in Improving Disease Activity in Adults with Active Idiopathic Inflammatory Myopathy (IIM)
|Trial type||Multicentre trial|
|Intervention||Abatacept / standard treatment / placebo|
|Principal investigator||Olivier Benveniste|
|+ infos on clinicaltrials.gov|